Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 1
2005 1
2006 1
2008 2
2009 2
2010 5
2011 7
2012 1
2013 3
2014 6
2015 5
2016 2
2017 2
2018 5
2019 7
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators. Schwartz GG, et al. N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7. N Engl J Med. 2018. PMID: 30403574 Free article. Clinical Trial.
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
Ray KK, Wright RS, Kallend D, Koenig W, Leiter LA, Raal FJ, Bisch JA, Richardson T, Jaros M, Wijngaard PLJ, Kastelein JJP; ORION-10 and ORION-11 Investigators. Ray KK, et al. N Engl J Med. 2020 Apr 16;382(16):1507-1519. doi: 10.1056/NEJMoa1912387. Epub 2020 Mar 18. N Engl J Med. 2020. PMID: 32187462 Clinical Trial.
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Ray KK, et al. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Lancet Diabetes Endocrinol. 2019. PMID: 31272931 Free article. Clinical Trial.
EUS-guided liver biopsy: the type of needle matters.
Confer BD, Walker JT, Khurana S, Unzueta A, Khara HS, Johal AS, Diehl DL. Confer BD, et al. Among authors: khurana s. Gastrointest Endosc. 2019 Aug;90(2):321-322. doi: 10.1016/j.gie.2019.04.207. Gastrointest Endosc. 2019. PMID: 31327346 No abstract available.
Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis.
Jadeja RN, Jones MA, Fromal O, Powell FL, Khurana S, Singh N, Martin PM. Jadeja RN, et al. Among authors: khurana s. Aging (Albany NY). 2019 Jan 18;11(2):386-400. doi: 10.18632/aging.101743. Aging (Albany NY). 2019. PMID: 30659164 Free PMC article.
Targeting Cholinergic System to Modulate Liver Injury.
Jadeja RN, Rachakonda VP, Khurana S. Jadeja RN, et al. Among authors: khurana s. Curr Drug Targets. 2018;19(8):938-944. doi: 10.2174/1389450118666170619090219. Curr Drug Targets. 2018. PMID: 28625139 Review.
52 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page